Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dendritic cells and immune-based therapies

R M Steinman1

  • 1Laboratory of Cellular Physiology and Immunology, The Rockefeller University, NY 10021, USA.

Experimental Hematology
|July 1, 1996
PubMed
Summary

Dendritic cells (DCs) are potent immune cells that can be generated ex vivo for therapeutic use. Research explores targeting antigens to DCs, like via DEC-205, for enhanced immunity and potential AIDS therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The cell surface of mouse lymphoid dendritic cells.

Immunology today·2014
Same author

Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity.

Journal of internal medicine·2011
Same author

The central nervous system in mucosal vaccination of rhesus macaques with simian immunodeficiency virus Deltanef.

Neuropathology and applied neurobiology·2007
Same author

Dendritic cells: translating innate to adaptive immunity.

Current topics in microbiology and immunology·2006
Same author

The dendritic cell advantage: New focus for immune-based therapies.

Drug news & perspectives·2003
Same author

The control of immunity and tolerance by dendritic cell.

Pathologie-biologie·2003

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Dendritic cells (DCs) are crucial white blood cells specializing in antigen capture and T-cell mediated immunity.
  • DCs are considered "nature's adjuvant" due to their ability to induce T-cell responses without additional adjuvants.
  • Generating large numbers of DCs ex vivo is an active area of research.

Purpose of the Study:

  • To explore the potential of dendritic cells (DCs) in immunotherapy and disease treatment.
  • To investigate methods for ex vivo generation and antigen-loading of DCs.
  • To understand the role of DCs in HIV-1 replication and potential therapeutic strategies.

Main Methods:

  • Ex vivo generation of DCs from CD34+ progenitors using granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF-alpha).
  • Identification and utilization of antigen receptors like DEC-205 for targeted antigen delivery to DCs.
  • Analysis of DC-mediated HIV-1 replication and syncytia formation with CD4+ T cells.

Main Results:

  • Methods for generating large numbers of DCs ex vivo are under development.
  • DEC-205 facilitates antigen uptake and presentation by DCs.
  • DCs play a significant role in promoting HIV-1 replication through syncytia formation with T cells.

Conclusions:

  • Dendritic cells hold promise for therapeutic applications, including vaccine development and treatment of infectious diseases like AIDS.
  • Targeting antigens to DCs via receptors like DEC-205 may enable the induction of active immunity.
  • Further research into DC biology could reveal new strategies for immune system manipulation in various clinical settings.

Related Experiment Videos